Overview

Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Status:
Completed

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate if the multi modality treatment pemetrexed combined with cisplatin and radiotherapy can lead to a better tumor control and/or a better side-effect profile in patients with locally advanced NSCLC. Patients will be randomized between 3 cycles of induction chemotherapy followed by concurrent chemoradiotherapy or concurrent chemoradiotherapy followed by 3 cycles of adjuvant combination chemotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

University Hospital, Antwerp

Collaborators:

Eli Lilly and Company
Universiteit Antwerpen

Treatments:

Cisplatin
Pemetrexed